Does the media prefer SENS or ECOR?

In the previous week, electroCore had 3 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 23 mentions for electroCore and 20 mentions for Senseonics Holdings, Inc. Common Stock. electroCore's average media sentiment score of 0.32 beat Senseonics Holdings, Inc. Common Stock's score of -0.08 indicating that electroCore is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Senseonics Holdings, Inc. Common Stock 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral electroCore 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, ECOR or PDEX?

Pro-Dex has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio electroCore $32.03M 2.80 -$13.97M -$1.66 N/A Pro-Dex $66.59M 3.25 $8.98M $3.62 18.76

Is ECOR or PDEX more profitable?

Pro-Dex has a net margin of 16.08% compared to electroCore's net margin of -39.96%. Pro-Dex's return on equity of 22.78% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -39.96% -1,956.38% -81.35% Pro-Dex 16.08% 22.78% 14.30%

Does the media favor ECOR or PDEX?

In the previous week, electroCore had 20 more articles in the media than Pro-Dex. MarketBeat recorded 23 mentions for electroCore and 3 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.20 beat electroCore's score of 0.32 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to KRMD or ECOR?

In the previous week, electroCore had 20 more articles in the media than KORU Medical Systems. MarketBeat recorded 23 mentions for electroCore and 3 mentions for KORU Medical Systems. electroCore's average media sentiment score of 0.32 beat KORU Medical Systems' score of 0.04 indicating that electroCore is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral electroCore 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Do analysts recommend INGN or ECOR?

electroCore has a consensus price target of $18.00, indicating a potential upside of 81.09%. Given electroCore's higher probable upside, analysts clearly believe electroCore is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 electroCore 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, INGN or ECOR?

electroCore has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inogen $354.30M 0.44 -$22.75M -$0.90 N/A electroCore $32.03M 2.80 -$13.97M -$1.66 N/A

Is INGN or ECOR more profitable?

Inogen has a net margin of -6.94% compared to electroCore's net margin of -39.96%. Inogen's return on equity of -13.17% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets Inogen -6.94% -13.17% -8.36% electroCore -39.96% -1,956.38% -81.35%

Does the media refer more to INGN or ECOR?

In the previous week, electroCore had 15 more articles in the media than Inogen. MarketBeat recorded 23 mentions for electroCore and 8 mentions for Inogen. Inogen's average media sentiment score of 0.38 beat electroCore's score of 0.32 indicating that Inogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral electroCore 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Is ECOR or APYX more profitable?

Apyx Medical has a net margin of -14.78% compared to electroCore's net margin of -39.96%. Apyx Medical's return on equity of -76.60% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -39.96% -1,956.38% -81.35% Apyx Medical -14.78% -76.60% -13.91%

Does the media favor ECOR or APYX?

In the previous week, electroCore had 2 more articles in the media than Apyx Medical. MarketBeat recorded 23 mentions for electroCore and 21 mentions for Apyx Medical. electroCore's average media sentiment score of 0.32 beat Apyx Medical's score of 0.07 indicating that electroCore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Apyx Medical 2 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

electroCore (ECOR) Competitors

$9.94 +0.54 (+5.74%)

Closing price 04:00 PM Eastern

Extended Trading

$9.88 -0.06 (-0.65%)

As of 05:21 PM Eastern

Compare

ECOR vs. SENS, PDEX, KRMD, INGN, and APYX

Should you buy electroCore stock or one of its competitors? electroCore's main competitors and comparable companies include Senseonics Holdings, Inc. Common Stock (SENS), Pro-Dex (PDEX), KORU Medical Systems (KRMD), Inogen (INGN), and Apyx Medical (APYX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does electroCore compare to Senseonics Holdings, Inc. Common Stock?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

electroCore has lower revenue, but higher earnings than Senseonics Holdings, Inc. Common Stock. electroCore is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	9.16	-$69.11M	-$2.23	N/A
electroCore	$32.03M	2.80	-$13.97M	-$1.66	N/A

electroCore has a net margin of -39.96% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Senseonics Holdings, Inc. Common Stock's return on equity of -165.80% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%
electroCore	-39.96%	-1,956.38%	-81.35%

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Comparatively, 7.8% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Senseonics Holdings, Inc. Common Stock has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market. Comparatively, electroCore has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market.

In the previous week, electroCore had 3 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 23 mentions for electroCore and 20 mentions for Senseonics Holdings, Inc. Common Stock. electroCore's average media sentiment score of 0.32 beat Senseonics Holdings, Inc. Common Stock's score of -0.08 indicating that electroCore is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
electroCore	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Senseonics Holdings, Inc. Common Stock presently has a consensus price target of $17.20, indicating a potential upside of 122.51%. electroCore has a consensus price target of $18.00, indicating a potential upside of 81.09%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, research analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Senseonics Holdings, Inc. Common Stock beats electroCore on 9 of the 16 factors compared between the two stocks.

How does electroCore compare to Pro-Dex?

electroCore (NASDAQ:ECOR) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

electroCore has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.02, suggesting that its share price is 98% less volatile than the broader market.

Pro-Dex has a net margin of 16.08% compared to electroCore's net margin of -39.96%. Pro-Dex's return on equity of 22.78% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
Pro-Dex	16.08%	22.78%	14.30%

electroCore currently has a consensus price target of $18.00, suggesting a potential upside of 81.09%. Pro-Dex has a consensus price target of $70.00, suggesting a potential upside of 3.09%. Given electroCore's higher probable upside, equities analysts clearly believe electroCore is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, electroCore had 20 more articles in the media than Pro-Dex. MarketBeat recorded 23 mentions for electroCore and 3 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.20 beat electroCore's score of 0.32 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Pro-Dex	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pro-Dex has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	2.80	-$13.97M	-$1.66	N/A
Pro-Dex	$66.59M	3.25	$8.98M	$3.62	18.76

26.7% of electroCore shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 7.8% of electroCore shares are owned by insiders. Comparatively, 45.9% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Pro-Dex beats electroCore on 12 of the 16 factors compared between the two stocks.

How does electroCore compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

In the previous week, electroCore had 20 more articles in the media than KORU Medical Systems. MarketBeat recorded 23 mentions for electroCore and 3 mentions for KORU Medical Systems. electroCore's average media sentiment score of 0.32 beat KORU Medical Systems' score of 0.04 indicating that electroCore is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
electroCore	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

KORU Medical Systems has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, electroCore has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than electroCore. KORU Medical Systems is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.72	-$2.64M	-$0.04	N/A
electroCore	$32.03M	2.80	-$13.97M	-$1.66	N/A

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 7.8% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

KORU Medical Systems currently has a consensus target price of $7.00, suggesting a potential upside of 110.21%. electroCore has a consensus target price of $18.00, suggesting a potential upside of 81.09%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

KORU Medical Systems has a net margin of -4.03% compared to electroCore's net margin of -39.96%. KORU Medical Systems' return on equity of -10.63% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
electroCore	-39.96%	-1,956.38%	-81.35%

Summary

KORU Medical Systems beats electroCore on 12 of the 16 factors compared between the two stocks.

How does electroCore compare to Inogen?

Inogen (NASDAQ:INGN) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

89.9% of Inogen shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 7.8% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

electroCore has a consensus price target of $18.00, indicating a potential upside of 81.09%. Given electroCore's higher probable upside, analysts clearly believe electroCore is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

electroCore has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$354.30M	0.44	-$22.75M	-$0.90	N/A
electroCore	$32.03M	2.80	-$13.97M	-$1.66	N/A

Inogen has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market. Comparatively, electroCore has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

Inogen has a net margin of -6.94% compared to electroCore's net margin of -39.96%. Inogen's return on equity of -13.17% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
electroCore	-39.96%	-1,956.38%	-81.35%

In the previous week, electroCore had 15 more articles in the media than Inogen. MarketBeat recorded 23 mentions for electroCore and 8 mentions for Inogen. Inogen's average media sentiment score of 0.38 beat electroCore's score of 0.32 indicating that Inogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
electroCore	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Inogen beats electroCore on 10 of the 17 factors compared between the two stocks.

How does electroCore compare to Apyx Medical?

electroCore (NASDAQ:ECOR) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

electroCore currently has a consensus price target of $18.00, suggesting a potential upside of 81.09%. Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 117.11%. Given Apyx Medical's stronger consensus rating and higher probable upside, analysts clearly believe Apyx Medical is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

26.7% of electroCore shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 7.8% of electroCore shares are held by company insiders. Comparatively, 15.9% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

electroCore has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market.

Apyx Medical has higher revenue and earnings than electroCore. Apyx Medical is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	2.80	-$13.97M	-$1.66	N/A
Apyx Medical	$52.84M	2.42	-$11.21M	-$0.20	N/A

Apyx Medical has a net margin of -14.78% compared to electroCore's net margin of -39.96%. Apyx Medical's return on equity of -76.60% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
Apyx Medical	-14.78%	-76.60%	-13.91%

In the previous week, electroCore had 2 more articles in the media than Apyx Medical. MarketBeat recorded 23 mentions for electroCore and 21 mentions for Apyx Medical. electroCore's average media sentiment score of 0.32 beat Apyx Medical's score of 0.07 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Apyx Medical	2 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Apyx Medical beats electroCore on 13 of the 17 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ECOR vs. The Competition

Export

Metric	electroCore	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$89.66M	$5.85B	$7.03B	$13.08B
Dividend Yield	N/A	1.76%	2.58%	10.74%
P/E Ratio	-5.99	25.27	270.65	25.25
Price / Sales	2.80	69.87	641.14	104.62
Price / Cash	N/A	33.59	70.59	50.58
Price / Book	-32.06	5.90	13.24	6.24
Net Income	-$13.97M	$148.67M	$3.45B	$347.70M
7 Day Performance	48.36%	3.09%	2.03%	1.92%
1 Month Performance	52.45%	3.13%	1.07%	1.05%
1 Year Performance	93.39%	8.30%	67.58%	19.53%

electroCore Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ECOR electroCore	2.7355 of 5 stars	$9.94 +5.7%	$18.00 +81.1%	+109.8%	$84.75M	$32.03M	N/A	50	Earnings Report Analyst Revision
SENS Senseonics Holdings, Inc. Common Stock	1.9553 of 5 stars	$5.40 +3.4%	$17.20 +218.5%	N/A	$218.42M	$35.26M	N/A	90	News Coverage Earnings Report Analyst Downgrade Analyst Revision Gap Down
PDEX Pro-Dex	1.8048 of 5 stars	$68.44 +7.6%	$70.00 +2.3%	+71.0%	$203.09M	$66.59M	18.91	140	Positive News
KRMD KORU Medical Systems	3.8041 of 5 stars	$4.27 +0.8%	$7.25 +70.0%	-20.5%	$194.30M	$41.13M	N/A	80
INGN Inogen	1.2433 of 5 stars	$6.92 +3.1%	N/A	-23.4%	$181.67M	$348.67M	N/A	1,030	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ECOR) was last updated on 8/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

electroCore (ECOR) Competitors

ECOR vs. SENS, PDEX, KRMD, INGN, and APYX

How does electroCore compare to Senseonics Holdings, Inc. Common Stock?

Summary

How does electroCore compare to Pro-Dex?

Summary

How does electroCore compare to KORU Medical Systems?

Summary

How does electroCore compare to Inogen?

Summary

How does electroCore compare to Apyx Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ECOR vs. The Competition

electroCore Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

electroCore (ECOR) Competitors

ECOR vs. SENS, PDEX, KRMD, INGN, and APYX

How does electroCore compare to Senseonics Holdings, Inc. Common Stock?

Which has better earnings and valuation, SENS or ECOR?

Is SENS or ECOR more profitable?

Do insiders & institutionals believe in SENS or ECOR?

Which has more volatility and risk, SENS or ECOR?

Does the media prefer SENS or ECOR?

Do analysts recommend SENS or ECOR?

Summary

How does electroCore compare to Pro-Dex?

Which has more volatility and risk, ECOR or PDEX?

Is ECOR or PDEX more profitable?

Do analysts rate ECOR or PDEX?

Does the media favor ECOR or PDEX?

Which has preferable earnings & valuation, ECOR or PDEX?

Do insiders and institutionals hold more shares of ECOR or PDEX?

Summary

How does electroCore compare to KORU Medical Systems?

Does the media refer more to KRMD or ECOR?

Which has more volatility & risk, KRMD or ECOR?

Which has preferable earnings & valuation, KRMD or ECOR?

Do insiders & institutionals have more ownership in KRMD or ECOR?

Do analysts rate KRMD or ECOR?

Is KRMD or ECOR more profitable?

Summary

How does electroCore compare to Inogen?

Do insiders and institutionals have more ownership in INGN or ECOR?

Do analysts recommend INGN or ECOR?

Which has preferable valuation and earnings, INGN or ECOR?

Which has more risk & volatility, INGN or ECOR?

Is INGN or ECOR more profitable?

Does the media refer more to INGN or ECOR?

Summary

How does electroCore compare to Apyx Medical?

Do analysts rate ECOR or APYX?

Do institutionals and insiders hold more shares of ECOR or APYX?

Which has more risk & volatility, ECOR or APYX?

Which has stronger valuation & earnings, ECOR or APYX?

Is ECOR or APYX more profitable?

Does the media favor ECOR or APYX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ECOR vs. The Competition

electroCore Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools